Dealbreaker on MSN
Presbyopia eye drop from startup Tenpoint gets FDA approval, paving way for $235M financing
Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and ...
YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...
MedPage Today on MSN
FDA OKs more eye drops that can replace reading glasses
Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...
Please provide your email address to receive an email when new articles are posted on . The RainDrop Dispenser Aid has a stabilizing bar and contoured handle to ease the use of single-dose eye drop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results